Ocular Monkeypox — United States, July–September 2022CDC/MMWR
17 October 2022
Cash-Goldwasser S, Labuda SM, McCormick DW, et al.
Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022Eurosurveillance
Paran N, et al.
In this study, the authors test for a correlation between MPXV DNA copies in patient specimens.
Monkeypox: UKHSA laboratory assessments of inactivation methodsGov.uk - UKHSA
Multiple protocols for inactivation of MPX are included in this resource, for example, Buffer AVL, 70% ethanol, L6 Buffer and others
Notice of Enforcement Discretion Regarding Monkeypox Medical WasteDOT
Discusses handling of medical waste based on whether testing indicates it is from the West African clade (Cat. B) or the Congo Basin clade (Cat. A)
Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine SupplyFDA
For individuals 18 years of age and older determined to be at high risk of monkeypox infection, the EUA now allows for a fraction of the JYNNEOS dose to be administered between the layers of the skin (intradermally).
08/23/2022: Lab Advisory: Monkeypox Virus Testing Considerations to Prevent False Positive Test ResultsCDC/Laboratory Outreach Communication System (LOCS)
Worldwide, there have been no reports of transmission of monkeypox virus through blood transfusion and the risk of transfusion-transmission remains theoretical.